Estey EH, Schrier SL. Treatment of high or very high risk myelodysplastic syndromes. UpToDate. 2017. https://www.uptodate.com/contents/treatment-of-high-or-very-high-risk-myelodysplastic-syndromes on October 12, 2017.
Festuccia M, Baker K, Gooley TA, et al. Hematopoietic cell transplantation in myelodysplastic syndromes after treatment with hypomethylating agents. Biol Blood Marrow Transplant. 2017. 23:1509-1514.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Myelodysplastic Syndromes. V.1.2018. Accessed at www.nccn.org/professionals/physician_gls/pdf/mds.pdf on October 12, 2017.